NASDAQ:RAPT

Companies

UBS lifts RAPT Therapeutics Inc [RAPT] price estimate. Who else is bullish?

RAPT Therapeutics Inc [NASDAQ: RAPT] traded at a low on Thursday, posting a -41.60 loss after which it closed the day’ session at $4.66. The results of the trading session contributed to over 4856295 shares changing hands. Over the past one week, the price volatility

Market

Cantor Fitzgerald slashes price target on RAPT Therapeutics Inc [RAPT] – find out why.

RAPT Therapeutics Inc [NASDAQ: RAPT] slipped around -19.1 points on Tuesday, while shares priced at $6.87 at the close of the session, down -73.55%. The company report on February 20, 2024 at 7:30 AM that RAPT Therapeutics Announces Clinical Hold on Studies Evaluating Zelnecirnon. –

NASDAQ:RAPT

UBS lifts RAPT Therapeutics Inc [RAPT] price estimate. Who else is bullish?

Cantor Fitzgerald slashes price target on RAPT Therapeutics Inc [RAPT] – find out why.

Quick Links

Categories

Get The Best Stocks To Trade Every Day!